6:15 PM
 | 
Mar 27, 2009
 |  BC Extra  |  Company News

Evotec restructures

Evotec (Xetra:EVT; NASDAQ:EVTC) will restructure and reduce headcount by about 50 (12%) to 370 to reduce cash burn, with the majority of reductions in SG&A. The company will focus on EVT 302, a reversible monoamine oxidase...

Read the full 174 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >